Skip to main content
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. logo

CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. — Investor Relations & Filings

Ticker · 000661 ISIN · CNE0000007J8 LEI · 300300X04OTKZG18WD66 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,288 across all filing types
Latest filing 2022-07-25 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000661

About CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD.

https://ccht.jl.cn

CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. is a diversified enterprise primarily focused on the research, development, production, and distribution of biopharmaceuticals and healthcare products. The company operates through several key subsidiaries, most notably GeneScience Pharmaceuticals, which specializes in recombinant human growth hormones and pediatric endocrinology treatments. Its product portfolio includes biological drugs, vaccines, and traditional Chinese medicines, targeting therapeutic areas such as growth disorders, infectious diseases, and oncology. The group emphasizes technological innovation and maintains a significant presence in the domestic market while expanding its international footprint. In addition to its core life sciences business, the company maintains interests in real estate development and infrastructure management.

Recent filings

Filing Released Lang Actions
独立董事关于第十届董事会第十五次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from the independent directors regarding the 15th meeting of the 10th board of directors of Changchun High-tech Industry (Group) Co., Ltd. It discusses the approval and legality of adjustments to the 2022 restricted stock and stock option incentive plan, including details about the grant date, number of shares/options, and compliance with relevant laws and regulations. The document is a formal opinion letter rather than a full report or announcement of financial results. It does not contain financial statements or earnings data, nor is it a regulatory announcement or certification. It is a governance-related document focusing on board-level decisions and compliance with incentive plan rules. Therefore, it fits best under Board/Management Information (MANG), which covers announcements related to board decisions and management matters.
2022-07-25 Chinese
北京市康达律师事务所关于长春高新技术产业（集团）股份有限公司独立董事公开征集表决权相关事项之法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the independent director's public solicitation of voting rights for a specific shareholders' meeting on July 25, 2022. It discusses the legal basis, qualifications of the solicitor, procedures, and results related to the solicitation of voting rights for proposals at a shareholders' meeting. The document does not contain financial statements, earnings data, or detailed financial analysis. It is not an announcement of voting results but a legal opinion on the solicitation process. The document length is 3742 characters, which is relatively short and focused on legal opinion rather than a full report. Therefore, it does not fit categories like Annual Report, Interim Report, or Earnings Release. It is also not a Proxy Solicitation & Information Statement (PSI) because it is a legal opinion letter, not the solicitation materials themselves. The best fitting category is Regulatory Filings (RNS), which covers miscellaneous regulatory announcements and legal opinions that do not fit other categories.
2022-07-25 Chinese
2022年第一次临时东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2022 first extraordinary general meeting of shareholders of Changchun High-tech Industry (Group) Co., Ltd. It includes information about the meeting date, attendance, voting results on various proposals, and legal opinions confirming the validity of the meeting and resolutions. The content focuses on shareholder voting outcomes and meeting procedural details rather than financial performance or management discussion. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is under 5,000 characters and contains detailed voting results, not just a brief announcement or a report publication notice. Therefore, it is not an RPA or RNS. Hence, the classification is DVA with high confidence.
2022-07-25 Chinese
关于公司2022年限制性股票与股票期权激励计划获得长春新区国有资产监督管理委员会批复的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the approval of a 2022 restricted stock and stock option incentive plan by a government supervisory committee. It references board and supervisory meetings and the need for shareholder approval before implementation. The document is short (762 characters) and serves as an official announcement of regulatory approval and next steps rather than the incentive plan details themselves. It does not contain financial statements or detailed report content. Therefore, it fits best as a Regulatory Filing (RNS) since it is a compliance announcement about corporate governance and incentive plan approval.
2022-07-19 Chinese
监事会关于2022年限制性股票与股票期权激励计划激励对象名单的公示情况说明及核查意见
Regulatory Filings Classification · 95% confidence The document is a public announcement by the supervisory board regarding the initial grant of restricted stock and stock option incentive plan recipients for 2022. It details the internal verification and public disclosure process of the incentive recipients' information, confirming compliance with relevant laws and regulations. The content focuses on the announcement and verification of the incentive plan participants rather than the incentive plan report itself or detailed financial data. The document length is short (1550 characters) and primarily serves as an official disclosure of the incentive plan grant and verification results. This fits best under Regulatory Filings (RNS) as it is a regulatory announcement about the incentive plan grant and verification, not a full report or detailed financial statement.
2022-07-19 Chinese
独立董事关于公开征集表决权的公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is an announcement by an independent director about publicly soliciting voting rights for a specific upcoming shareholders' meeting (the 2022 first extraordinary general meeting). It details the process for shareholders to authorize the director to vote on their behalf on several proposals related to a stock incentive plan. The document includes legal disclaimers, the director's independence, voting instructions, and procedural details for submitting proxy forms. It does not contain financial statements, earnings data, or detailed management discussion. It is not a report of voting results but a solicitation for voting rights prior to the meeting. The document length is 4395 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits best as a Proxy Solicitation & Information Statement (PSI).
2022-07-08 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.